搜尋結果

共 1996 個結果
頁數:1...33 34 35 36 37 38 39 40 41 ...100

Anti-science thinking, bad public education, and trashy films

Widespread social media availability has enabled the rise of anti-science thinking that threatens to undermine public safety. You see these in anti-vaxxers, flat Earth believers, and all sorts of weir ...More

EJ Insight2021-07-27

社交處方 解疫時代孤寂

人類和絕大部分哺乳類動物一樣,都喜歡群居,不愛獨處。雖然現代科技發達,人們不單可以足不出戶便能知天下事,而且可 ...全文

今日信報副刊文化身心掃描陳仲謀醫生2021年07月27日

America’s Republicans are killing their voters

On May 14, 1962, the agriculture commissioner of Montana, Lowell Purdy, launched what would become one of the century’s great platitudes. “If we can put a man on the Moon,” he declared, seven years be ...More

EJ Insight2021-07-26

Rich potential of China infrastructure REITs

The recent successful listing of nine new Chinese infrastructure real estate investment trusts (C-REITs) portends a promising future for this asset class. Infrastructure spending is a key growth pilla ...More

EJ Insight2021-07-23

新冠是個美麗謠言?

印尼傳媒報道,一名神經治療師為證明新冠病毒安全,與友人前往探望確診患者,兩人在沒佩戴個人防護裝備的情況下,輪流 ...全文

今日信報副刊文化忽然文化占飛2021年07月23日

Cancelling the Olympics?

Could there be a case for cancelling the Olympics, espe ...全文

今日信報時事評論EJ InsightBrian Wong2021年07月23日

Cancelling the Olympics?

Could there be a case for cancelling the Olympics, especially in light of the recent surge in athletes testing positive for COVID-19? At first glance, the argument seems unconvincing. After all, vacci ...More

EJ Insight2021-07-22

越南製造加工出口(00422) 內幕消息 / 其他-業務發展最新情況

越南製造加工出口(00422) 越南仁澤生產設施在COVID-19於越南最近發展下的最新營運情況(355KB, ...全文

即時新聞港交所通告2021年07月21日

城大動物醫學及生命科學院院長 認為香港人現在可除口罩

Nikolaus Osterrieder是上任剛滿一年的香港城市大學賽馬會動物醫學及生命科學院院長。他來自德國 ...全文

今日信報副刊文化訪談錄譚淑美2021年07月20日

聯泰控股(00311) 盈利警告 / 內幕消息

聯泰控股(00311) 盈利預告及有關COVID-19疫苗接種率的最新情況(323KB, pdf) ...全文

即時新聞港交所通告2021年07月19日

和鉑醫藥-B(02142) 其他-業務發展最新情況

和鉑醫藥-B(02142) 自願公告 - 有關與西奈山醫療系統就COVID-19中和抗體的合作協議之業務更新( ...全文

即時新聞港交所通告2021年07月19日

Pandemic, NSL cast large shadow over Book Fair

The Covid-19 pandemic and National Security Law (NSL) have cast a large shadow over the Hong Kong Book Fair which opened on July 14 and runs until Tuesday. It was the first to be held for two years. T ...More

EJ Insight2021-07-19

How to boost response rates to census survey

The second phase of data collection of the 2021 Population Census was launched in mid July. Households that have yet to submit the completed questionnaires will be visited by census fieldworkers to co ...More

EJ Insight2021-07-19

永嘉集團(03322) 內幕消息 / 其他-業務發展最新情況

永嘉集團(03322) 內幕消息 - 越南廠房在COVID-19於越南最近發展下的最新營運情況(275KB, ...全文

即時新聞港交所通告2021年07月16日

開拓藥業-B(09939) 其他-業務發展最新情況

開拓藥業-B(09939) 自願公告 開拓藥業於巴拉圭獲得普克魯胺治療COVID-19的首個緊急使用授權(EU ...全文

即時新聞港交所通告2021年07月16日

Japan’s quiet Olympics

On July 8, the Japanese government declared a state of emergency in Tokyo until August 22, owing to the COVID-19 pandemic. That means the Tokyo Olympic Games (July 23-August 8) will be subject to stri ...More

EJ Insight2021-07-16

A human-rights approach to global challenges

The COVID-19 pandemic has recast the world for millions of people. Or, more correctly, the pandemic has exposed and aggravated deep inequalities of race, gender, and class across societies, and highli ...More

EJ Insight2021-07-15

The global food system isn’t working

The year 2020 was unforgettable for all of us, and tragic for many. No one had imagined that a lethal virus originating in horseshoe bats could spread so fast and upend our lives so thoroughly. And in ...More

EJ Insight2021-07-15

Carrie Lam sees rise in support rating

Someone should send Chief Executive Carrie Lam some flowers. Well, her popularity has bounced back to reach a two-year high. The Hong Kong Public Opinion Program concluded in its latest survey that he ...More

EJ Insight2021-07-14

藥明生物料中期利潤增逾1.35倍

藥明生物(02269)發盈喜,預期於截至6月底止中期股東利潤按年將增長1.35倍以上。2020年中期利潤為7. ...全文

即時新聞重要通告2021年07月14日

頁數:1...33 34 35 36 37 38 39 40 41 ...100

信報簡介 | 服務條款 | 私隱條款 | 免責聲明 | 廣告查詢 | 加入信報 | 聯絡信報

股票及指數資料由財經智珠網有限公司提供。期貨指數資料由天滙財經有限公司提供。外滙及黃金報價由路透社提供。

本網站的內容概不構成任何投資意見,本網站內容亦並非就任何個別投資者的特定投資目標、財務狀況及個別需要而編製。投資者不應只按本網站內容進行投資。在作出任何投資決定前,投資者應考慮產品的特點、其本身的投資目標、可承受的風險程度及其他因素,並適當地尋求獨立的財務及專業意見。本網站及其資訊供應商竭力提供準確而可靠的資料,但並不保證資料絕對無誤,資料如有錯漏而令閣下蒙受損失,本公司概不負責。